New Jersey announces multistate settlement over 23andMe genetic-data breach claims
New Jersey Attorney General Jennifer Davenport announced July 14, 2026, that the state is participating in a multistate settlement of bankruptcy claims against 23andMe involving a genetic-data breach.
The announcement identifies New Jersey as part of the multistate action and connects the claims to the breach of genetic data held by the company. It does not, however, provide the central terms consumers would need to know whether they could receive relief or what action they may need to take.
Settlement is tied to 23andMe bankruptcy claims
The settlement concerns claims against 23andMe in its bankruptcy proceedings, according to the New Jersey Office of the Attorney General’s Division of Consumer Affairs. The claims arise from a genetic-data breach.
New Jersey’s role is as a participating state in the multistate settlement. The available information does not identify the other participating states or state how many jurisdictions are included in the effort.
The announcement also does not state the settlement’s dollar amount. No figure for the total settlement, any allocation to New Jersey, or any potential individual consumer payment was provided in the available information.
What is known — and what is not yet disclosed
The state’s announcement establishes that a settlement has been announced over bankruptcy claims connected to a breach involving genetic information. It also establishes that New Jersey is participating in the multistate action.
But the available announcement information does not identify how many New Jersey residents were affected, which consumers may be eligible for any relief, or whether a consumer claims process will be required. It likewise does not provide a deadline for filing a claim or instructions for submitting one.
Those omissions are significant for consumers because participation in a multistate settlement does not itself establish that every New Jersey 23andMe customer is covered or will receive compensation. The terms governing eligibility, claim administration and any payment process have not been provided in the available source material.
The available information also does not establish that 23andMe admitted liability. The announcement describes a settlement of bankruptcy claims; it does not supply the underlying agreement or terms that would address admissions, releases or other conditions of the resolution.
Why the announcement matters
The claims involve genetic data, a type of information that can raise consumer-protection and privacy concerns. The settlement may affect eligible New Jersey consumers and the administration of data-breach claims in 23andMe’s bankruptcy proceedings, but the precise scope remains unconfirmed.
For now, the verified development is New Jersey’s participation in the multistate settlement announced by Davenport on July 14. The announcement does not establish the number of people who may be covered or the value of any relief that may be available.
What happens next
No consumer deadline or immediate filing requirement was identified in the available announcement information. Consumers should not assume that the announcement alone creates a requirement to submit a claim or guarantees a payment.
Any future eligibility standards, claims instructions, payment schedule or other settlement details will need to be confirmed through the complete state release and relevant bankruptcy-court documents. Until those materials provide further terms, the settlement amount, consumer process and deadlines remain unknown.
Sources
- Attorney General Jennifer Davenport Announces Multistate Settlement of Bankruptcy Claims Against 23andMe Over Genetic Data Breach, New Jersey Office of Attorney General, Division of Consumer Affairs